Not Yet RecruitingPhase 3

Cardiovascular Protection After Preeclampsia With Enalapril

60 participantsStarted 2025-11-15

Plain-language summary

The purpose of this study is to learn if postpartum women are willing to be randomized to different blood pressure medicines after delivery and how that affects blood pressure in women with hypertensive disorders of pregnancy.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Postpartum individuals * ≥18 years old * Hypertensive disorder of pregnancy * Enrolled in Women and Infants Hospital Hypertension Equity remote monitoring program. Exclusion Criteria: * Maternal cardiac disease * Individuals with pre-pregnancy hypertension or diabetes * Allergy or contraindication to enalapril

What they're measuring

Feasibility of enrollment

Timeframe: 4 months

Feasibility of retention

Timeframe: 4 months

Trial details

NCT IDNCT07222852

SponsorWomen and Infants Hospital of Rhode Island

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-10-15

Contact for this trial

Alisse Hauspurg, MD

401-274-1122 ahauspurg@carene.org

View on ClinicalTrials.gov More Preeclampsia trials